Clinical Pharmacy Specialist; Surgery, Trauma, and Orthopedics
University of Cincinnati Medical Center
Andexanet Alfa Versus 4F-PCC for Reversal of Apixaban and Rivaroxaban in Trauma Patients
Sunday, March 22, 2026
11:00 AM - 12:00 PM Central Time
Disclosure information not submitted.
Anti-Xa Monitored Compared to Empiric Initiation of VTE Prophylaxis in Trauma Patients on DOAC
Sunday, March 22, 2026
11:00 AM - 12:00 PM Central Time
Disclosure information not submitted.
